- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
-
- 长期趋势：
已有1家主力机构披露2024-12-31报告期持股数据，持仓量总计32.51万股，占流通A股0.05%
- 波段诊断：
-
技术面诊股
诊断结果：3.4技术面打败了41%的股票
技术面评分前10的股票
近期的平均成本为7.07元。
平均成本
近期的平均成本为7.07元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"7.07","date":1741598072,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2025.03.11","stock":"0.00","trade":null,"ind":"0.41"},{"date":"2025.03.10","stock":"0.57","trade":null,"ind":"-0.19"},{"date":"2025.03.07","stock":"-0.70","trade":null,"ind":"-0.25"},{"date":"2025.03.06","stock":"1.28","trade":null,"ind":"1.17"},{"date":"2025.03.05","stock":"-2.50","trade":null,"ind":"0.53"},{"date":"2025.03.04","stock":"1.69","trade":null,"ind":"0.22"},{"date":"2025.03.03","stock":"1.58","trade":null,"ind":"-0.12"},{"date":"2025.02.28","stock":"-2.79","trade":null,"ind":"-1.98"},{"date":"2025.02.27","stock":"-0.14","trade":null,"ind":"0.23"},{"date":"2025.02.26","stock":"0.98","trade":null,"ind":"1.02"},{"date":"2025.02.25","stock":"-1.11","trade":null,"ind":"-0.80"},{"date":"2025.02.24","stock":"-0.14","trade":null,"ind":"-0.18"},{"date":"2025.02.21","stock":"-0.69","trade":null,"ind":"0.85"},{"date":"2025.02.20","stock":"0.97","trade":null,"ind":"-0.02"},{"date":"2025.02.19","stock":"0.70","trade":null,"ind":"0.81"},{"date":"2025.02.18","stock":"-3.12","trade":null,"ind":"-0.93"},{"date":"2025.02.17","stock":"0.55","trade":null,"ind":"0.27"},{"date":"2025.02.14","stock":"2.23","trade":null,"ind":"0.43"},{"date":"2025.02.13","stock":"-1.38","trade":null,"ind":"-0.42"},{"date":"2025.02.12","stock":"-0.55","trade":null,"ind":"0.85"},{"date":"2025.02.11","stock":"-0.68","trade":null,"ind":"-0.12"}]
海利生物,上证指数,医疗器械指数
压力支撑
该股压力位为7.05元，支撑位为6.97元。
[{"text":"\u538b\u529b\u4f4d","value":"7.05","date":1741622400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"6.97","date":1741622400,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.5资金面打败了58%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：03月12日 12:31
| 机构今日流向(万元) | -736.91 | 机构5日流向(万元) | -2650.11 |
| 机构10日流向(万元) | -4073.44 | 机构20日流向(万元) | -10085.36 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少22979.11万股，其中基金数没有增加，主力净减仓19家，请投资者中长期谨慎为宜。
截止2024-12-31，共1家主力机构（基金1家），持仓量总计32.51万股，占流通A股0.05%
其中，基金持仓与2024-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有32.51万股
从主力名单中消失：20家 ，原持有23011.62万股
其中，基金持仓与2024-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有32.51万股
从主力名单中消失：20家 ，原持有23011.62万股
消息面诊股
诊断结果：8.4消息面打败了97%的股票
今日有利好新闻的公司
近期该股利好消息较多，投资者可加强关注。
更多>>个股资讯
- 海利生物：3月11日获融资买入313.37万元，占
2025-03-12 - 海利生物：3月10日获融资买入330.62万元，占
2025-03-11 - 海利生物：3月7日获融资买入266.22万元
2025-03-10 - 海利生物：全资子公司通过高新技术企业重新认定
2025-03-06 - 海利生物：3月5日获融资买入560.01万元
2025-03-06 - 海利生物：3月3日获融资买入158.38万元，占当
2025-03-04 - 海利生物：2月28日获融资买入354.72万元
2025-03-03 - 农药兽药板块盘中走弱，驱动力领跌6.1%
2025-02-28 - 海利生物：2月27日获融资买入384.11万元
2025-02-28 - 海利生物：2月26日获融资买入311.77万元，占
2025-02-27
消息列表
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-01-24 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-01-01 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-01-01 |
| 一般消息 | 重大事项 | 关联交易 | 2025-01-01 |
| 一般消息 | 重大事项 | 关联交易 | 2024-12-04 |
| 一般消息 | 高管变动 | 因公司业务调整 | 2024-12-02 |
| 一般消息 | 高管变动 | 因个人原因 | 2024-11-27 |
| 一般消息 | 股东大会 | 临时股东大会 | 2024-11-12 |
| 一般消息 | 重大事项 | 关联交易 | 2024-10-17 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-31 |
| 一般消息 | 重大事项 | 关联交易 | 2024-08-31 |
| 一般消息 | 高管变动 | 个人原因 | 2024-06-28 |
| 一般消息 | 重大事项 | 关联交易 | 2024-05-24 |
| 利好 | 分红转增 | 10派0.287元(含税) | 2024-04-30 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2024-04-17 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 1条 | 1条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：0.0行业面打败了9%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2025.03.11","price":"0.41","value":null},{"date":"2025.03.10","price":"-0.19","value":null},{"date":"2025.03.07","price":"-0.25","value":null},{"date":"2025.03.06","price":"1.17","value":null},{"date":"2025.03.05","price":"0.53","value":null},{"date":"2025.03.04","price":"0.22","value":null},{"date":"2025.03.03","price":"-0.12","value":null},{"date":"2025.02.28","price":"-1.98","value":null},{"date":"2025.02.27","price":"0.23","value":null},{"date":"2025.02.26","price":"1.02","value":null},{"date":"2025.02.25","price":"-0.80","value":null},{"date":"2025.02.24","price":"-0.18","value":null},{"date":"2025.02.21","price":"0.85","value":null},{"date":"2025.02.20","price":"-0.02","value":null},{"date":"2025.02.19","price":"0.81","value":null},{"date":"2025.02.18","price":"-0.93","value":null},{"date":"2025.02.17","price":"0.27","value":null},{"date":"2025.02.14","price":"0.43","value":null},{"date":"2025.02.13","price":"-0.42","value":null},{"date":"2025.02.12","price":"0.85","value":null},{"date":"2025.02.11","price":"-0.12","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 迪瑞医疗 | 150.55% | -0.31% | 4.4分 |
| 2 | 安必平 | 96.64% | 10.01% | 4.1分 |
| 3 | 华大智造 | 47.92% | -4.39% | 4.1分 |
| 4 | 热景生物 | 42.11% | 29.80% | 4.6分 |
| 5 | 圣湘生物 | 21.07% | 5.21% | 5.0分 |
| 6 | 九强生物 | 20.63% | 0.92% | 4.3分 |
| 8 | 天智航 | 18.16% | -0.28% | 4.3分 |
| 10 | 超研股份 | 16.01% | -4.43% | 4.3分 |
| 12 | 祥生医疗 | 14.19% | -4.61% | 3.6分 |
| 14 | 楚天科技 | 12.14% | 3.70% | 4.2分 |
| 16 | 达安基因 | 11.40% | -3.15% | 3.4分 |
| 18 | 科美诊断 | 9.65% | -2.85% | 4.2分 |
| 20 | 浩欧博 | 8.81% | -0.96% | 5.2分 |
| 22 | 仁度生物 | 8.37% | 0.67% | 4.2分 |
| 24 | 奕瑞科技 | 8.27% | 1.81% | 4.8分 |
| 26 | 正海生物 | 7.96% | 5.62% | 4.3分 |
| 28 | 康众医疗 | 7.38% | 2.94% | 4.5分 |
| 30 | 麦澜德 | 7.07% | 4.20% | 4.9分 |
| 32 | 博拓生物 | 7.00% | -0.25% | 5.2分 |
| 34 | 威高骨科 | 6.18% | -2.50% | 5.4分 |
| 36 | 迈克生物 | 5.53% | 3.67% | 4.7分 |
| 38 | 蓝帆医疗 | 5.43% | -1.32% | 4.6分 |
| 40 | 基蛋生物 | 4.82% | 0.23% | 4.8分 |
| 42 | 之江生物 | 4.70% | 0.69% | 3.8分 |
| 44 | 睿昂基因 | 4.36% | -0.56% | 4.5分 |
| 46 | 尚荣医疗 | 4.23% | 0.29% | 5.2分 |
| 48 | 国发股份 | 4.00% | 5.41% | 4.6分 |
| 50 | 正川股份 | 3.97% | 1.15% | 4.9分 |
| 52 | 海尔生物 | 3.91% | -2.06% | 4.5分 |
| 54 | 华兰股份 | 3.81% | 5.06% | 4.4分 |
| 56 | 爱威科技 | 3.60% | 2.21% | 4.8分 |
| 58 | 透景生命 | 3.27% | 0.53% | 3.8分 |
| 60 | 冠昊生物 | 3.00% | 0.23% | 4.1分 |
| 62 | 赛科希德 | 2.56% | -1.21% | 4.6分 |
| 64 | 凯利泰 | 2.37% | 4.16% | 4.9分 |
| 66 | 东星医疗 | 2.20% | 0.54% | 4.5分 |
| 68 | 澳华内镜 | 1.89% | 5.92% | 4.6分 |
| 70 | 乐普医疗 | 1.79% | 0.93% | 3.8分 |
| 72 | 联影医疗 | 1.67% | -2.81% | 4.2分 |
| 74 | 东方生物 | 1.14% | 0.97% | 3.8分 |
| 76 | 维力医疗 | 0.51% | 1.88% | 5.2分 |
| 78 | 易瑞生物 | 0.46% | 0.11% | 4.8分 |
| 80 | 明德生物 | 0.11% | -0.37% | 4.2分 |
| 82 | 春立医疗 | 0.00% | -0.81% | 3.7分 |
| 84 | 科华生物 | -0.33% | -1.15% | 3.3分 |
| 86 | 康德莱 | -0.53% | -0.53% | 4.9分 |
| 88 | 振德医疗 | -1.48% | -0.28% | 5.4分 |
| 90 | 康拓医疗 | -2.36% | -7.03% | 5.1分 |
| 92 | 奥精医疗 | -2.54% | -0.82% | 3.6分 |
| 94 | 济高发展 | -2.56% | -4.69% | 3.7分 |
| 96 | 海利生物 | -2.74% | -1.39% | 4.4分 |
| 98 | 迈瑞医疗 | -3.00% | -0.37% | 5.2分 |
| 100 | 开立医疗 | -3.11% | -1.98% | 3.9分 |
| 102 | 拱东医疗 | -3.57% | 0.31% | 5.5分 |
| 104 | 海泰新光 | -3.78% | 0.74% | 4.8分 |
| 106 | 健尔康 | -3.97% | -1.86% | 4.6分 |
| 108 | 爱迪特 | -4.34% | 0.58% | 4.0分 |
| 110 | 奥美医疗 | -4.74% | -1.88% | 5.2分 |
| 112 | 中红医疗 | -4.92% | -2.33% | 4.4分 |
| 114 | 东方海洋 | -5.88% | -2.44% | 3.6分 |
| 116 | 华强科技 | -6.29% | -0.38% | 4.4分 |
| 118 | 爱博医疗 | -10.01% | -2.73% | 3.6分 |
| 120 | 康为世纪 | -10.81% | -7.22% | 2.7分 |
| 122 | 心脉医疗 | -13.18% | -0.12% | 4.4分 |
| 124 | - | -57.89% | -14.16% | 分 |
| 126 | 乐心医疗 | - | -4.57% | 5.0分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 90/249 ， 77/249。
[{"date":"2024-09-30","value":"1.62","vol":"4.78"},{"date":"2024-06-30","value":"1.22","vol":"3.54"},{"date":"2024-03-31","value":"-0.30","vol":"1.67"},{"date":"2023-12-31","value":"5.33","vol":"12.40"},{"date":"2023-09-30","value":"6.43","vol":"5.64"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.62 | 1.22 | -0.30 | 5.33 | 6.43 |
| 行业(%) | 4.78 | 3.54 | 1.67 | 12.40 | 5.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"49.08","vol":"53.43"},{"date":"2024-06-30","value":"47.78","vol":"53.63"},{"date":"2024-03-31","value":"43.74","vol":"53.16"},{"date":"2023-12-31","value":"51.39","vol":"53.54"},{"date":"2023-09-30","value":"50.85","vol":"53.90"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
49.08 | 47.78 | 43.74 | 51.39 | 50.85 |
| 行业(%) | 53.43 | 53.63 | 53.16 | 53.54 | 53.90 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 97/249 ， 107/249。
[{"date":"2024-09-30","value":"-10.37","vol":"1.29"},{"date":"2024-06-30","value":"-9.50","vol":"0.73"},{"date":"2024-03-31","value":"-1.31","vol":"-0.80"},{"date":"2023-12-31","value":"-19.76","vol":"-6.88"},{"date":"2023-09-30","value":"-28.56","vol":"-6.02"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-10.37 | -9.50 | -1.31 | -19.76 | -28.56 |
| 行业(%) | 1.29 | 0.73 | -0.80 | -6.88 | -6.02 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"-72.99","vol":"-19.70"},{"date":"2024-06-30","value":"-81.50","vol":"9.59"},{"date":"2024-03-31","value":"-126.13","vol":"-15.89"},{"date":"2023-12-31","value":"-48.30","vol":"-23.68"},{"date":"2023-09-30","value":"86.47","vol":"0.42"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-72.99 | -81.50 | -126.13 | -48.30 | 86.47 |
| 行业(%) | -19.70 | 9.59 | -15.89 | -23.68 | 0.42 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 110/249 ， 94/249。
[{"date":"2024-09-30","value":"0.11","vol":"0.26"},{"date":"2024-06-30","value":"0.07","vol":"0.18"},{"date":"2024-03-31","value":"0.04","vol":"0.09"},{"date":"2023-12-31","value":"0.15","vol":"0.37"},{"date":"2023-09-30","value":"0.13","vol":"0.27"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.11 | 0.07 | 0.04 | 0.15 | 0.13 |
| 行业(次) | 0.26 | 0.18 | 0.09 | 0.37 | 0.27 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.95","vol":"1.68"},{"date":"2024-06-30","value":"0.55","vol":"1.13"},{"date":"2024-03-31","value":"0.40","vol":"0.55"},{"date":"2023-12-31","value":"0.94","vol":"2.28"},{"date":"2023-09-30","value":"0.80","vol":"1.59"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.95 | 0.55 | 0.40 | 0.94 | 0.80 |
| 行业(次) | 1.68 | 1.13 | 0.55 | 2.28 | 1.59 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"14.99","vol":"15.40"},{"date":"2024-06-30","value":"34.58","vol":"12.72"},{"date":"2024-03-31","value":"-1.75","vol":"2.14"},{"date":"2023-12-31","value":"106.41","vol":"39.09"},{"date":"2023-09-30","value":"-17.35","vol":"18.01"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 14.99 | 34.58 | -1.75 | 106.41 | -17.35 |
| 行业 | 15.40 | 12.72 | 2.14 | 39.09 | 18.01 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.01"},{"date":"2024-06-30","value":"0.33","vol":"2.32"},{"date":"2024-03-31","value":"","vol":"0.06"},{"date":"2023-12-31","value":"0.19","vol":"2.85"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.33 | - | 0.19 | - |
| 行业 | 0.01 | 2.32 | 0.06 | 2.85 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 37/249 ， 49/249。
[{"date":"2024-09-30","value":"3.15","vol":"5.98"},{"date":"2024-06-30","value":"1.41","vol":"5.99"},{"date":"2024-03-31","value":"1.39","vol":"6.56"},{"date":"2023-12-31","value":"1.35","vol":"5.82"},{"date":"2023-09-30","value":"1.59","vol":"6.72"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.15 | 1.41 | 1.39 | 1.35 | 1.59 |
| 行业 | 5.98 | 5.99 | 6.56 | 5.82 | 6.72 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"2.87","vol":"4.82"},{"date":"2024-06-30","value":"1.12","vol":"4.93"},{"date":"2024-03-31","value":"1.14","vol":"5.47"},{"date":"2023-12-31","value":"1.08","vol":"4.82"},{"date":"2023-09-30","value":"1.29","vol":"5.64"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.87 | 1.12 | 1.14 | 1.08 | 1.29 |
| 行业 | 4.82 | 4.93 | 5.47 | 4.82 | 5.64 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 46/249 ， 47/249。
[{"date":"2024-09-30","value":"24.51","vol":"21.14"},{"date":"2024-06-30","value":"24.58","vol":"21.13"},{"date":"2024-03-31","value":"28.23","vol":"20.72"},{"date":"2023-12-31","value":"29.13","vol":"21.25"},{"date":"2023-09-30","value":"27.33","vol":"21.16"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
24.51 | 24.58 | 28.23 | 29.13 | 27.33 |
| 行业(%) | 21.14 | 21.13 | 20.72 | 21.25 | 21.16 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.31","vol":"0.38"},{"date":"2024-06-30","value":"0.31","vol":"0.37"},{"date":"2024-03-31","value":"0.38","vol":"0.37"},{"date":"2023-12-31","value":"0.40","vol":"0.37"},{"date":"2023-09-30","value":"0.36","vol":"0.35"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.31 | 0.31 | 0.38 | 0.40 | 0.36 |
| 行业(%) | 0.38 | 0.37 | 0.37 | 0.37 | 0.35 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2024年的收益，请投资者后续关注。
[{"date":"2020","yellowRectValue":"0.09","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"0.54","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.22","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.63","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]